Polaryx Therapeutics, Inc. Common Stock Financial Flexibility Index
Polaryx Therapeutics, Inc. Common Stock financial flexibility index. Polaryx Therapeutics, Inc. Common Stock (PLYX) has a Financial Flexibility Index of -1.57x as of June 2026. Free cash flow of $-1.37 Million (operating CF $-1.37 Million minus capex $0.00) represents -2% of total liabilities ($873.00K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Polaryx Therapeutics, Inc. Common Stock (2023–2025)
Financial flexibility index of Polaryx Therapeutics, Inc. Common Stock from 2023 to 2025. Historical Financial Flexibility Index trend for Polaryx Therapeutics, Inc. Common Stock across 3 annual periods. Explore Polaryx Therapeutics, Inc. Common Stock cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Polaryx Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2023–2025)
Polaryx Therapeutics, Inc. Common Stock financial flexibility index by year from 2023 to 2025. Year-by-year free cash flow to debt coverage for Polaryx Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see PLYX cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.61x | $-3.94 Million | $-3.94 Million | $855.00K | ▲ +48.2% |
| 2024 | -8.90x | $-2.57 Million | $-2.57 Million | $289.00K | ▼ -5241.9% |
| 2023 | -0.17x | $-173.00K | $-173.00K | $1.04 Million | — |